Premium
PANcreatic‐DERived factor: Novel hormone PANDERing to glucose regulation
Author(s) -
Wilson Camella G.,
Robert-Cooperman Claudia E.,
Burkhardt Brant R.
Publication year - 2011
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2011.05.059
Subject(s) - endocrine system , pancreas , hormone , function (biology) , cytokine , exocrine pancreas , endocrinology , biology , medicine , microbiology and biotechnology
PANcreatic‐DERived factor (PANDER, FAM3B) is a member of the FAM3 family of cytokine molecules that were initially described in 2002. PANDER expression is primarily localized to the endocrine pancreas and is secreted from both pancreatic α and β‐cells. Initial characterization of PANDER revealed a potential role in pancreatic islet apoptosis. However, recent animal models have indicated PANDER functions as a hormone by regulating glucose levels via interaction with both the liver and the endocrine pancreas. An understanding of the function of PANDER can further the insight into the mechanisms of glucose regulation and potentially provide additional therapeutic targets for the treatment of diabetes. This review details the supporting data demonstrating PANDER has a biological function in glycemic regulation.